Item 16. Form 10-K Summary.

None.

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on December 20, 2019.

THE COOPER COMPANIES, INC.

By: /s/ Albert G. White, III

Albert G. White, III

President & Chief Executive Officer

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the dates set forth opposite their respective names.



Signature	Capacity	Date
/s/ ALBERT G. WHITE, III	President, Chief Executive Officer and Director (Principal Executive Officer)	December 20, 2019
(Albert G. White, III)
/s/ A. THOMAS BENDER	Chairman of the Board	December 20, 2019
(A. Thomas Bender)
/s/ ALLAN E. RUBENSTEIN, M.D.	Vice Chairman of the Board and Lead Director	December 20, 2019
(Allan E. Rubenstein)
/s/ BRIAN G. ANDREWS	Senior Vice President, Chief Financial Officer & Treasurer	December 20, 2019
(Brian G. Andrews)	(Principal Financial Officer)
/s/ AGOSTINO RICUPATI	Chief Accounting Officer & Senior Vice President, Finance & Tax	December 20, 2019
(Agostino Ricupati)	(Principal Accounting Officer)
/s/ COLLEEN E. JAY	Director	December 20, 2019
(Colleen E. Jay)
/s/ MICHAEL H. KALKSTEIN	Director	December 20, 2019
(Michael H. Kalkstein)
/s/ WILLIAM A. KOZY	Director	December 20, 2019
(William A. Kozy)
/s/ JODY S. LINDELL	Director	December 20, 2019
(Jody S. Lindell)
/s/ GARY S. PETERSMEYER	Director	December 20, 2019
(Gary S. Petersmeyer)
/s/ ROBERT S. WEISS	Director	December 20, 2019
(Robert S. Weiss)

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

CORPORATE INFORMATION



BOARD OF DIRECTORS A. Thomas Bender Chairman of the Board Allan E. Rubenstein, M.D. Vice Chairman and Lead Director, Chairman of the Board, CalAsia Pharmaceuticals, Inc. Colleen E. Jay Director Michael H. Kalkstein Of Counsel, Palo Alto Office, Dechert LLP William A. Kozy Director Jody S. Lindell President and Chief Executive Officer, S.G. Management, Inc. Gary S. Petersmeyer Director Robert S. Weiss Director Albert G. White, III President & Chief Executive Officer COMMITTEES OF THE BOARD Audit Committee Jody S. Lindell (Chairman) Michael H. Kalkstein William A. Kozy Gary Petersmeyer Corporate Governance and Nominating Committee Allan E. Rubenstein, M.D. (Chairman) Michael H. Kalkstein William A. Kozy Colleen E. Jay Organization and Compensation Committee Michael H. Kalkstein (Chairman) Colleen E. Jay Jody S. Lindell Gary S. Petersmeyer		EXECUTIVE OFFICERS Albert G. White, III President and Chief Executive Officer Randal L. Golden Vice President, Secretary and General Counsel Agostino Ricupati Senior Vice President Finance and Tax, and Chief Accounting Officer Brian G. Andrews Senior Vice President, Chief Financial Officer & Treasurer Holly Sheffield Executive Vice President and Chief Strategy Officer Robert D. Auerbach, M.D President of CooperSurgical, Inc. Daniel G. McBride, Esq. Executive Vice President and Chief Operating Officer; President of CooperVision, Inc. PRINCIPAL SUBSIDIARIES CooperVision, Inc. 6101 Bollinger Canyon Road Suite 500 San Ramon, CA 94583 925-460-3600 www.coopervision.com CooperSurgical, Inc. 75 Corporate Drive Trumbull, CT 06611 203-601-5200 www.coopersurgical.com CORPORATE OFFICES The Cooper Companies, Inc. 6101 Bollinger Canyon Road Suite 500 San Ramon, CA 94583 925-460-3600 www.coopercos.com		INVESTOR INFORMATION Recent news releases, the annual report on Securities and Exchange Commission Form 10-K, information about the Company's corporate governance program, recent investor presentations, replays of quarterly conference calls and historical stock quotes are available on our Web site at www.coopercos.com. INVESTOR RELATIONS CONTACT Kim Duncan Vice President of Investor Relations & Administration 6101 Bollinger Canyon Road Suite 500 San Ramon, CA 94583 Voice: 925-460-3663 E-mail: ir@cooperco.com ANNUAL MEETING The Cooper Companies will hold its Annual Stockholders' Meeting in March 2020. TRANSFER AGENT American Stock Transfer & Trust Company 6201 15th Avenue Brooklyn, NY 11219 800-937-5449 TRADEMARKS The Cooper Companies, Inc., its subsidiaries or affiliates own, license or distribute the registered trademarks, common law trademarks and trade names referenced in this report. INDEPENDENT AUDITORS KPMG LLP STOCK EXCHANGE LISTING The New York Stock Exchange Ticker Symbol “COO”

Previous: Item 15. Exhibits and Financial Statement Schedules.